Nifty
:
22795.90
Sensex
:
75311.06
-117.25 (-0.51%)
-424.90 (-0.56%)
Nifty
Sensex
:
:
22795.90
75311.06
-117.25 (-0.51%)
-424.90 (-0.56%)

Laurus Labs Ltd.

Pharmaceuticals & Drugs - API

Rating :
N/A

BSE: 540222 | NSE: LAURUSLABS

NSE BSE
636.80
06-Feb-2025
  • Open
  • High
  • Low
  • Previous Close
  •  634.85
  •  642.00
  •  631.60
  •  631.10
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  2671614
  •  17023.78
  •  646.20
  •  373.10

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 28,097.75
  • 140.31
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 30,774.60
  • 0.15%
  • 6.65

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 27.60%
  • 8.16%
  • 22.74%
  • FII
  • DII
  • Others
  • 25.56%
  • 11.70%
  • 4.24%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 14.28
  • 12.23
  • 0.71

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 14.83
  • 6.61
  • -11.38

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 9.35
  • -8.19
  • -41.41

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 32.61
  • 32.99
  • 37.58

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 5.67
  • 7.02
  • 6.27

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 18.41
  • 21.08
  • 23.51

Earnings Forecasts:

Description
2024
2025
2026
2027
Adj EPS
2.98
6.35
11.19
15.43
P/E Ratio
182.33
85.55
48.57
35.21
Revenue
5002
5552
6474
7369
EBITDA
749
1073
1465
1817
Net Income
161
333
603
833
ROA
2
4.4
7.7
8.8
P/Bk Ratio
7.12
6.64
5.93
5.16
ROE
3.94
8.11
12.5
14.81
FCFF
-181.32
97.45
146.53
323.12
FCFF Yield
-0.57
0.31
0.46
1.01

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Net Sales
1,415.05
1,194.92
18.42%
1,223.70
1,224.45
-0.06%
1,194.91
1,181.79
1.11%
1,439.67
1,380.90
4.26%
Expenses
1,129.90
1,013.50
11.48%
1,045.37
1,036.58
0.85%
1,023.71
1,015.07
0.85%
1,198.18
1,095.36
9.39%
EBITDA
285.15
181.42
57.18%
178.33
187.87
-5.08%
171.20
166.72
2.69%
241.49
285.54
-15.43%
EBIDTM
20.15%
15.18%
14.57%
15.34%
14.33%
14.11%
16.77%
20.68%
Other Income
9.42
2.43
287.65%
4.60
1.78
158.43%
2.51
3.60
-30.28%
18.53
1.71
983.63%
Interest
57.80
50.82
13.73%
52.61
42.39
24.11%
49.19
39.19
25.52%
50.50
53.10
-4.90%
Depreciation
106.09
98.41
7.80%
107.51
93.37
15.14%
106.06
90.55
17.13%
102.25
87.01
17.52%
PBT
130.68
34.62
277.47%
22.81
53.89
-57.67%
18.46
40.58
-54.51%
107.27
147.14
-27.10%
Tax
40.07
9.45
324.02%
5.09
14.57
-65.07%
6.25
12.18
-48.69%
31.95
39.90
-19.92%
PAT
90.61
25.17
259.99%
17.72
39.32
-54.93%
12.21
28.40
-57.01%
75.32
107.24
-29.77%
PATM
6.40%
2.11%
1.45%
3.21%
1.02%
2.40%
5.23%
7.77%
EPS
1.71
0.43
297.67%
0.37
0.69
-46.38%
0.23
0.46
-50.00%
1.40
1.91
-26.70%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
5,273.33
5,040.83
6,040.55
4,935.57
4,813.51
2,831.72
2,291.92
2,056.17
1,904.65
1,777.58
1,326.59
Net Sales Growth
5.85%
-16.55%
22.39%
2.54%
69.99%
23.55%
11.47%
7.96%
7.15%
34.00%
 
Cost Of Goods Sold
2,417.31
2,374.35
2,729.67
2,133.89
2,107.62
1,382.88
1,224.80
1,056.02
989.29
1,000.15
821.27
Gross Profit
2,856.02
2,666.48
3,310.88
2,801.68
2,705.89
1,448.84
1,067.12
1,000.15
915.36
777.43
505.32
GP Margin
54.16%
52.90%
54.81%
56.77%
56.21%
51.16%
46.56%
48.64%
48.06%
43.74%
38.09%
Total Expenditure
4,397.16
4,263.33
4,448.36
3,513.14
3,262.83
2,267.17
1,935.93
1,642.85
1,497.01
1,415.38
1,131.46
Power & Fuel Cost
-
338.15
324.10
204.47
157.75
136.77
109.37
94.21
66.27
57.95
49.86
% Of Sales
-
6.71%
5.37%
4.14%
3.28%
4.83%
4.77%
4.58%
3.48%
3.26%
3.76%
Employee Cost
-
614.85
557.43
469.55
397.04
320.77
276.33
238.14
204.73
175.46
131.38
% Of Sales
-
12.20%
9.23%
9.51%
8.25%
11.33%
12.06%
11.58%
10.75%
9.87%
9.90%
Manufacturing Exp.
-
611.80
522.90
441.18
364.78
239.50
178.96
150.78
139.47
106.97
80.61
% Of Sales
-
12.14%
8.66%
8.94%
7.58%
8.46%
7.81%
7.33%
7.32%
6.02%
6.08%
General & Admin Exp.
-
157.89
151.15
146.49
133.28
114.23
97.48
73.17
65.42
49.09
28.39
% Of Sales
-
3.13%
2.50%
2.97%
2.77%
4.03%
4.25%
3.56%
3.43%
2.76%
2.14%
Selling & Distn. Exp.
-
134.49
116.14
101.98
91.65
61.53
31.96
24.09
22.65
16.49
12.46
% Of Sales
-
2.67%
1.92%
2.07%
1.90%
2.17%
1.39%
1.17%
1.19%
0.93%
0.94%
Miscellaneous Exp.
-
31.80
46.97
15.58
10.71
11.49
17.03
6.44
9.18
9.27
12.46
% Of Sales
-
0.63%
0.78%
0.32%
0.22%
0.41%
0.74%
0.31%
0.48%
0.52%
0.56%
EBITDA
876.17
777.50
1,592.19
1,422.43
1,550.68
564.55
355.99
413.32
407.64
362.20
195.13
EBITDA Margin
16.62%
15.42%
26.36%
28.82%
32.22%
19.94%
15.53%
20.10%
21.40%
20.38%
14.71%
Other Income
35.06
26.34
6.00
15.30
23.66
5.92
16.15
29.19
33.44
4.36
34.07
Interest
210.10
182.90
165.17
102.39
68.16
89.59
88.19
79.64
99.90
111.11
101.11
Depreciation
421.91
384.58
324.08
251.49
205.07
187.27
164.19
125.45
105.98
86.41
61.53
PBT
279.22
236.36
1,108.94
1,083.85
1,301.11
293.61
119.75
237.42
235.19
169.04
66.57
Tax
83.36
68.15
312.30
251.42
317.29
38.34
25.99
69.81
43.86
34.90
-1.55
Tax Rate
29.85%
28.83%
28.16%
23.20%
24.39%
13.06%
21.70%
29.40%
18.65%
20.65%
-2.33%
PAT
195.86
166.49
793.37
827.72
983.58
255.27
93.76
167.61
191.33
134.14
68.12
PAT before Minority Interest
195.53
168.21
796.64
832.43
983.82
255.27
93.76
167.61
191.33
134.14
68.12
Minority Interest
-0.33
-1.72
-3.27
-4.71
-0.24
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
3.71%
3.30%
13.13%
16.77%
20.43%
9.01%
4.09%
8.15%
10.05%
7.55%
5.13%
PAT Growth
-2.13%
-79.01%
-4.15%
-15.85%
285.31%
172.26%
-44.06%
-12.40%
42.63%
96.92%
 
EPS
3.63
3.09
14.71
15.35
18.24
4.73
1.74
3.11
3.55
2.49
1.26

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
4,110.95
4,037.53
3,351.19
2,597.55
1,769.77
1,558.41
1,482.64
1,330.45
856.80
722.10
Share Capital
107.79
107.73
107.47
107.32
106.91
106.44
106.03
105.76
82.38
82.13
Total Reserves
3,981.69
3,917.72
3,234.55
2,485.31
1,658.23
1,446.60
1,370.75
1,218.84
771.47
637.03
Non-Current Liabilities
1,159.18
1,179.48
927.98
692.84
214.24
295.49
174.30
132.34
428.11
363.73
Secured Loans
798.23
761.42
596.34
429.16
165.02
258.71
141.66
124.56
353.61
303.68
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
106.13
0.00
Long Term Provisions
93.47
81.47
72.67
63.19
45.85
30.05
20.84
14.59
6.77
5.13
Current Liabilities
3,112.28
2,432.26
2,681.01
2,457.15
1,692.38
1,423.90
1,306.89
1,120.75
883.75
802.49
Trade Payables
1,051.24
710.65
876.37
1,178.69
615.63
488.31
312.33
263.10
247.61
230.81
Other Current Liabilities
610.73
640.75
839.73
367.25
261.47
244.50
231.26
199.11
141.05
133.34
Short Term Borrowings
1,389.29
995.77
910.72
886.12
790.51
684.21
758.52
644.17
481.42
431.63
Short Term Provisions
61.02
85.09
54.19
25.09
24.77
6.89
4.78
14.37
13.66
6.70
Total Liabilities
8,387.03
7,660.40
6,968.04
5,750.69
3,676.39
3,277.80
2,963.83
2,583.54
2,168.66
1,888.32
Net Block
3,890.01
3,408.62
2,652.47
2,170.62
1,726.34
1,629.07
1,480.80
1,229.93
1,021.03
801.01
Gross Block
5,652.20
4,794.82
3,750.20
3,027.97
2,387.71
2,105.42
1,793.75
1,418.58
1,106.33
986.17
Accumulated Depreciation
1,762.19
1,386.20
1,097.73
857.35
661.37
476.35
312.95
188.65
85.30
185.16
Non Current Assets
4,552.06
4,198.72
3,623.43
2,675.83
1,864.33
1,814.84
1,716.23
1,443.71
1,165.92
1,024.41
Capital Work in Progress
422.84
550.78
813.22
362.17
67.18
109.63
163.18
143.26
69.60
109.67
Non Current Investment
123.98
49.90
30.81
3.41
3.41
3.40
3.40
3.40
7.04
7.45
Long Term Loans & Adv.
83.50
160.58
84.11
108.52
40.80
25.58
29.36
25.95
29.22
93.94
Other Non Current Assets
31.73
28.84
42.82
31.11
26.60
47.16
39.50
41.17
39.03
12.34
Current Assets
3,834.97
3,461.68
3,344.61
3,074.86
1,812.06
1,462.96
1,247.59
1,139.82
1,002.73
862.27
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
1,845.41
1,684.81
1,760.30
1,575.45
905.22
681.94
584.78
509.05
487.09
475.50
Sundry Debtors
1,662.92
1,580.44
1,354.18
1,306.06
791.42
709.94
570.59
567.61
444.86
285.07
Cash & Bank
141.65
48.46
75.94
48.46
1.74
3.02
3.06
4.09
28.77
58.88
Other Current Assets
184.99
39.07
19.71
56.50
113.68
68.06
89.16
59.08
42.00
42.82
Short Term Loans & Adv.
147.16
108.90
134.48
88.39
61.91
35.22
58.63
25.01
23.86
22.75
Net Current Assets
722.69
1,029.42
663.60
617.71
119.68
39.05
-59.30
19.07
118.98
59.78
Total Assets
8,387.03
7,660.40
6,968.04
5,750.69
3,676.39
3,277.80
2,963.82
2,583.53
2,168.65
1,888.32

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Cash From Operating Activity
665.69
993.90
911.10
733.00
347.42
297.66
342.49
331.99
181.97
-64.71
PBT
236.36
1,108.94
1,083.85
1,301.11
293.61
119.75
237.42
235.19
169.04
66.57
Adjustment
562.92
485.71
351.13
254.45
293.21
247.69
216.47
199.38
200.57
136.26
Changes in Working Capital
-29.02
-315.26
-341.61
-594.06
-199.76
-44.46
-49.48
-52.45
-154.37
-250.72
Cash after chg. in Working capital
770.26
1,279.39
1,093.37
961.50
387.06
322.99
404.41
382.12
215.23
-47.89
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-104.57
-285.49
-182.27
-228.50
-39.64
-25.32
-61.91
-50.13
-33.26
-16.82
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-822.42
-996.06
-914.34
-940.99
-221.13
-252.88
-384.15
-288.67
-312.20
-396.95
Net Fixed Assets
-288.19
-567.41
-1,025.56
-572.84
-236.25
-254.84
-394.43
-354.15
-76.75
-353.86
Net Investments
-250.75
-22.40
-42.83
-260.57
-0.01
-6.57
-1.22
-24.40
-7.01
-18.65
Others
-283.48
-406.25
154.05
-107.58
15.13
8.53
11.50
89.88
-228.44
-24.44
Cash from Financing Activity
249.83
-26.64
30.26
254.70
-127.66
-44.77
42.24
-53.61
103.32
486.08
Net Cash Inflow / Outflow
93.10
-28.80
27.02
46.71
-1.37
0.02
0.59
-10.30
-26.91
24.42
Opening Cash & Equivalents
45.67
75.35
48.46
1.69
2.97
3.00
2.42
12.81
39.53
15.11
Closing Cash & Equivalent
138.94
45.67
75.35
48.46
1.69
2.97
3.00
2.42
12.81
39.53

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
75.88
74.73
62.19
48.32
33.02
29.18
27.86
25.05
99.86
83.92
ROA
2.10%
10.89%
13.09%
20.87%
7.34%
3.00%
6.04%
8.05%
6.61%
4.31%
ROE
4.15%
21.63%
28.05%
45.15%
15.39%
6.19%
11.97%
18.12%
18.65%
14.47%
ROCE
6.64%
22.97%
25.97%
39.82%
14.14%
8.22%
13.68%
16.52%
16.35%
13.74%
Fixed Asset Turnover
0.97
1.41
1.46
1.78
1.26
1.18
1.29
1.53
1.73
1.66
Receivable days
117.42
88.66
98.37
79.52
96.76
101.97
100.40
95.66
73.56
65.47
Inventory Days
127.81
104.09
123.34
94.05
102.29
100.87
96.48
94.12
97.00
109.61
Payable days
135.42
106.10
175.76
155.37
145.69
72.80
61.13
59.14
58.52
69.29
Cash Conversion Cycle
109.81
86.64
45.95
18.21
53.36
130.03
135.75
130.64
112.05
105.79
Total Debt/Equity
0.61
0.49
0.52
0.56
0.60
0.67
0.66
0.64
1.20
1.14
Interest Cover
2.29
7.71
11.59
20.09
4.28
2.36
3.98
3.35
2.52
1.66

Annual Reports:

FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015

News Update:


  • Laurus Labs - Quarterly Results
    24th Jan 2025, 14:58 PM

    Read More
  • Laurus Labs’ arm gets one observation from USFDA
    23rd Jan 2025, 11:58 AM

    Laurus Generics Inc. has undergone a Post-marketing Adverse Drug Experience inspection by USFDA

    Read More
  • Laurus Labs’ arm secures equity investments from Eight Roads Ventures, F-Prime Capital, Laurus Labs
    9th Dec 2024, 10:50 AM

    The Promoters of Laurus Bio have also been issued share warrants

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.